Floatz logo

Gallium-68 Labelled Fap-2286

Pulmonary Fibrosis

Thomas HoperadiopharmaceuticalPhase 1Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Pulmonary Fibrosis cohort.

Asset / SponsorPhaseRating
N-Acetyl-L-Cysteine
Boehringer Ingelheim
Phase 3BB
Nintedanib
Boehringer Ingelheim
Phase 3BB
Pirfenidone
Boehringer Ingelheim
Phase 2BB
Admilparant
Bristol-Myers Squibb
Phase 3BB
Sildenafil
Alicia Gerke
Phase 3BB

View all 38 →

Same molecule, other indications

Gallium-68 Labelled Fap-2286 is also rated in:

breast cancerDormant
CCC
Indicative ·
53 / 100
View asset →
Myocardial FibrosisDormant
CC
Indicative ·
47 / 100
View asset →
fibrotic liver diseaseDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →